Phase II Study of TAS-106 to Treat Head and Neck Cancer
Status:
Terminated
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether TAS-106 is effective to patients with
recurrent or metastatic head and neck cancer refractory to platinum based chemotherapy.